Problem statement: Answer the MCQ question.
Question: Which compound exhibits a 3.788\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
a) COc1ccc(NC(=O)CN2CCN(CC(=O)Nc3ccc(F)cc3)CC2)c(OC)c1
b) CC1CC(=O)Nc2ccccc2N1C(=O)CSc1ncnc2sccc12
c) CN(CC(=O)NCc1ccccn1)S(=O)(=O)c1ccc(Cl)cc1
d) Cc1cc(C)nc(NS(=O)(=O)c2ccc(NC(=O)CSc3nc(-c4ccccc4)c(C#N)c(=O)[nH]3)cc2)n1
e) Cc1c(CNC2CCC(C)CC2)c(C(=O)O)c(C)n1Cc1ccccc1
Answer: b. CC1CC(=O)Nc2ccccc2N1C(=O)CSc1ncnc2sccc12
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC1CC(=O)Nc2ccccc2N1C(=O)CSc1ncnc2sccc12
CC1CC(=O)Nc2ccccc2N1C(=O)CSc1ncnc2sccc12
4-methyl-5-(2-thieno[2,3-d]pyrimidin-4-ylsulfanylacetyl)-3,4-dihydro-1H-1,5-benzodiazepin-2-one